IHS Poster Library

IHC poster presenters are offered the opportunity to extend the life of their poster by posting it on the IHS website.

The posters are available as downloadable PDF files.

You can search the posters by congress year, category or a title word, or browse all the posters below the search box.

All poster content is the responsibility of the authors.

Search results

244 Results
Category Title Email
Migraine A pharmacokinetic bioequivalence study of fremanezumab administered subcutaneously using an autoinjector and a prefilled syringe
Migraine Efficacy with fremanezumab in migraine patients with comorbid moderate to severe depression and documented inadequate response to 2-4 classes of migraine preventive treatments: subgroup analysis of the randomized, placebo-controlled FOCUS study
Migraine Early onset of response to fremanezumab in migraine patients with moderate to severe depression and documented inadequate response to 2-4 classes of migraine preventive treatments: subgroup analysis of the randomized, placebo-controlled FOCUS study
Migraine Efficacy of fremanezumab in migraine patients with medication overuse and documented inadequate response to 2-4 classes of migraine preventive treatments: subgroup analysis of the randomized, placebo-controlled FOCUS study
Migraine Clinically meaningful responses to fremanezumab in patients with migraine and documented inadequate response to 2-4 classes of migraine preventive medications in the international, multicenter, randomized, placebo-controlled FOCUS study
Migraine Effect of fremanezumab on quality of life and health status in migraine patients with documented inadequate response to 2-4 classes of migraine preventive medications in the randomized, placebo-controlled FOCUS study
Migraine Impact of fremanezumab on migraine-associated symptoms in patients with documented inadequate response to 2-4 classes of migraine preventive medications in the international, multicenter, randomized, placebo-controlled FOCUS study
Migraine Changes in anxiety, sleep, and need for rescue medications in migraine patients on fremanezumab therapy: patient survey results following completion of a 1-year extension study
Migraine Long-term impact of fremanezumab on response rate, acute headache medication use, and disability in chronic migraine patients with acute medication overuse at baseline: results of a 1-year study
Migraine Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with chronic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
Page 21 of 25